118 related articles for article (PubMed ID: 26645061)
1. Author response.
Wen PY; Norden AD
Neurology; 2015 Sep; 85(12):1090. PubMed ID: 26645061
[No Abstract] [Full Text] [Related]
2. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Chamberlain MC
Neurology; 2015 Sep; 85(12):1090. PubMed ID: 26391415
[No Abstract] [Full Text] [Related]
3. Comment: Medical therapy for recurrent or progressive meningiomas remains elusive.
Iwamoto FM
Neurology; 2015 Jan; 84(3):285. PubMed ID: 25527267
[No Abstract] [Full Text] [Related]
4. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Norden AD; Ligon KL; Hammond SN; Muzikansky A; Reardon DA; Kaley TJ; Batchelor TT; Plotkin SR; Raizer JJ; Wong ET; Drappatz J; Lesser GJ; Haidar S; Beroukhim R; Lee EQ; Doherty L; Lafrankie D; Gaffey SC; Gerard M; Smith KH; McCluskey C; Phuphanich S; Wen PY
Neurology; 2015 Jan; 84(3):280-6. PubMed ID: 25527270
[TBL] [Abstract][Full Text] [Related]
5. Resected atypical meningioma relapsed to anaplastic meningioma during luteinizing hormone-releasing hormone agonist therapy.
Nicosia L; Bucpapaj R; Barresi V; Damante R; Napoli G; Ghimenton C; Giaj-Levra N; Cancedda M; Flaminio S; Figlia V; Alongi F
Neurochirurgie; 2021 Apr; 67(2):193-197. PubMed ID: 33190809
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.
Johnson DR; Kimmel DW; Burch PA; Cascino TL; Giannini C; Wu W; Buckner JC
Neuro Oncol; 2011 May; 13(5):530-5. PubMed ID: 21558077
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy: What is its role in meningioma?
Sherman WJ; Raizer JJ
Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea for treatment of meningioma.
Cusimano MD
J Neurosurg; 1998 May; 88(5):938-9. PubMed ID: 9576275
[No Abstract] [Full Text] [Related]
9. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
Chamberlain MC; Glantz MJ; Fadul CE
Neurology; 2007 Sep; 69(10):969-73. PubMed ID: 17785665
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response.
Pellerino A; Soffietti R; Rudà R
J Neurooncol; 2016 Mar; 127(1):201-3. PubMed ID: 26614515
[No Abstract] [Full Text] [Related]
11. Successful mifepristone treatment of recurrent, inoperable meningioma.
Haak HR; de Keizer RJ; Hagenouw-Taal JC; van Seters AP; Vielvoye GJ; van Dulken H
Lancet; 1990 Jul; 336(8707):124-5. PubMed ID: 1975312
[No Abstract] [Full Text] [Related]
12. Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer.
Tsutsui T; Miyashita K; Sabit H; Fukui I; Hayashi Y; Mizokami A; Ikeda H; Nagatani H; Nakada M
World Neurosurg; 2016 Jul; 91():670.e1-6. PubMed ID: 27046016
[TBL] [Abstract][Full Text] [Related]
13. Treatment for rare brain tumors veers from traditional tack.
McBride G
J Natl Cancer Inst; 1997 Jul; 89(13):912-3. PubMed ID: 9214668
[No Abstract] [Full Text] [Related]
14. Sunitinib for atypical and anaplastic meningioma.
Rahman A
Lancet Oncol; 2014 Sep; 15(10):e424. PubMed ID: 25328951
[No Abstract] [Full Text] [Related]
15. Treatment of high risk or recurrent meningiomas with hydroxyurea.
Rosenthal MA; Ashley DL; Cher L
J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703
[TBL] [Abstract][Full Text] [Related]
16. Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy.
Simó M; Argyriou AA; Macià M; Plans G; Majós C; Vidal N; Gil M; Bruna J
Cancer Chemother Pharmacol; 2014 May; 73(5):919-23. PubMed ID: 24619496
[TBL] [Abstract][Full Text] [Related]
17. Recurrent psammocarcinoma of the peritoneum with complete response to tamoxifen therapy.
Molpus KL; Wu H; Fuller AF
Gynecol Oncol; 1998 Feb; 68(2):206-9. PubMed ID: 9514798
[TBL] [Abstract][Full Text] [Related]
18. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
Chamberlain MC
Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint blockade in recurrent meningiomas: Lessons for future management.
Pant A; Lim M
Neuro Oncol; 2022 Jan; 24(1):114-115. PubMed ID: 34626195
[No Abstract] [Full Text] [Related]
20. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
